Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.20
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Shanghai Fosun Pharmaceutical Net Income (Quarterly) : 157.09M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 157.09M |
| March 31, 2026 | 155.92M |
| December 31, 2025 | 168.09M |
| September 30, 2025 | 133.55M |
| June 30, 2025 | 160.18M |
| March 31, 2025 | 129.39M |
| December 31, 2024 | 138.25M |
| September 30, 2024 | 135.16M |
| June 30, 2024 | 105.43M |
| March 31, 2024 | 109.38M |
| December 31, 2023 | 33.37M |
| September 30, 2023 | 83.98M |
| June 30, 2023 | 132.70M |
| March 31, 2023 | 162.85M |
| December 31, 2022 | 162.47M |
| September 30, 2022 | 133.75M |
| June 30, 2022 | 183.06M |
| March 31, 2022 | 99.89M |
| December 31, 2021 | 164.62M |
| September 30, 2021 | 182.62M |
| June 30, 2021 | 274.74M |
| March 31, 2021 | 151.04M |
| December 31, 2020 | 179.58M |
| September 30, 2020 | 121.41M |
| June 30, 2020 | 177.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 92.92M |
| December 31, 2019 | 182.81M |
| September 30, 2019 | 90.65M |
| June 30, 2019 | 142.02M |
| March 31, 2019 | 126.13M |
| December 31, 2018 | 98.43M |
| September 30, 2018 | 88.39M |
| June 30, 2018 | 141.14M |
| March 31, 2018 | 131.76M |
| December 31, 2017 | 125.17M |
| September 30, 2017 | 124.47M |
| June 30, 2017 | 158.94M |
| March 31, 2017 | 121.36M |
| December 31, 2016 | 100.83M |
| September 30, 2016 | 117.64M |
| June 30, 2016 | 151.06M |
| March 31, 2016 | 116.45M |
| December 31, 2015 | 108.54M |
| September 30, 2015 | 104.86M |
| June 30, 2015 | 145.18M |
| March 31, 2015 | 98.67M |
| December 31, 2014 | 93.66M |
| September 30, 2014 | 104.08M |
| June 30, 2014 | 107.14M |
| March 31, 2014 | 79.44M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.523B |
| Total Expenses (Quarterly) | 1.398B |
| EPS Diluted (Quarterly) | 0.0473 |
| Enterprise Value | 11.43B |
| Gross Profit Margin (Quarterly) | 46.17% |
| Profit Margin (Quarterly) | 10.31% |
| Earnings Yield | 8.35% |
| Operating Earnings Yield | 6.26% |
| Normalized Earnings Yield | 8.332 |